The Seattle Vaccine Trials Unit (VTU), led by Dr. Julie McElrath, director of Fred Hutch division of Vaccine and Infectious Disease implements an array of studies researching HIV and other infectious diseases.
In the world of HIV vaccine research, the VTU is one of the 22 research sites within the HIV Vaccine Trials Network (HVTN), the world’s largest publicly funded multi-disciplinary international collaboration. The HVTN network is funded to conduct phase I, II, and III clinical trials designed to test the safety and efficacy of HIV vaccines. As a local site of the HVTN, the Seattle VTU works to enroll volunteers in a number of research studies.
Located on Seattle’s First Hill, the VTU is responsible for the recruitment, selection and enrollment of local volunteers and clinical monitoring of volunteers.
Since opening in 1987, the Seattle VTU has worked with local community members who are interested in participating in research and has provided education to the local community. We work with many community based organizations such as African American Reach and Teach Ministries, Entre Hermanos, Gay City, Multicultural HIV/Hepatitis Action Network and Lifelong AIDS Alliance.
Together with the help of our volunteers, we hope to end the HIV/AIDS pandemic.
Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.